echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Roche's head of neuroscience and rare disease R&D joins Novartis

    Roche's head of neuroscience and rare disease R&D joins Novartis

    • Last Update: 2021-12-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    It was recently learned that Bob Baloh, vice president and global head of neuroscience and rare disease research at Roche's drug research and early development division, has joined Novartis as the global head of the company's Institute of Biomedical Research (NIBR) in the field of neuroscience diseases


    It is understood that Baloh has worked at Roche for one year.


    At Novartis, Baloh will help the research industry suffer setbacks, including many diseases and disorders in the unresolved areas of human biology


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.